Standalone Audited Financial Result for the Quarter & Year ended on 31.03.2025

Revenue declinedEBITDA margin compressionRelated-party transactionsResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.9%Reaction day

₹4.55

prior close

₹4.45

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%+0.6% vs market

Pharmaceuticals peers, median of 147sector-0.3%+1.2% vs sector

On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250 and 1.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+4.0

10m

+3.6

15m

+1.1

30m

+3.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.9+0.3+0.6-0.3+1.2

Next day

+1.1+0.7+0.4+0.2+0.9

-1.1+1.0-2.1-0.2-0.9

-0.4+1.1-1.5-0.3-0.2

-0.4+0.8-1.2-0.7+0.2

-0.2+1.3-1.5-0.7+0.4

-1.1+1.7-2.8-0.4-0.7

15d

-4.4+1.5-5.9-1.0-3.3

-3.3+4.0-7.3+0.0-3.3

-9.0+1.8-10.8+0.0-9.1

-4.8-1.0-3.9-3.4-1.4

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 147Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Zenith Healthcare Limited posted FY25 revenue from operations of ₹1,132.97 lakhs, down about 21.7% from ₹1,447.24 lakhs in FY24. Other income rose to ₹43.14 lakhs from ₹26.25 lakhs, so total income fell to ₹1,176.11 lakhs. The company still managed profit before tax of ₹27.92 lakhs (vs ₹27.58 lakhs), but profit after tax dropped sharply to ₹6.70 lakhs from ₹20.35 lakhs, pushing EPS down to ₹0.013 from ₹0.038. In Q4 alone, revenue grew ~11.6% to ₹342.53 lakhs and the company swung back to a ₹10.97 lakh profit versus a ₹25.76 lakh loss a year earlier. The statutory auditor M/s Doshi Doshi & Co issued an unmodified (clean) opinion.

Likely market impact

Sharply lower full-year revenue and a steep drop in net profit signal weak top-line momentum despite a small Q4 recovery, which is likely to be viewed negatively by shareholders. The clean audit, debt-free balance sheet and positive operating cash flow are positives, but the shrinking earnings power may weigh on the stock in the near term.